FUT4 is abnormally upregulated in different types of cancers, such as colorectal cancer [19], breast cancer [20] and lung adenocarcinoma [21], and the up-regulation of FUT4 is associated with tumor metastases, higher recurrence, and poorer survival in tumor patients. Here, FUT4 is linked to breast carcinoma.